A Phase 2, Randomized, Double-Blind, Parallel-Group Study to Assess the Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With Usual Type Vulvar Intraepithelial Neoplasia
Latest Information Update: 09 Feb 2023
At a glance
Most Recent Events
- 22 Nov 2019 Results assessing safety and tolerability and explore pharmacodynamics and efficacy of omiganan in external anogenital warts published in the British Journal of Clinical Pharmacology
- 01 Aug 2017 Status changed from active, no longer recruiting to completed.
- 21 Sep 2016 Status changed from recruiting to active, no longer recruiting.